These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 9189143

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE.
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [Abstract] [Full Text] [Related]

  • 3. Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET.
    Kushner M, Tobin M, Alavi A, Chawluk J, Rosen M, Fazekas F, Alavi J, Reivich M.
    J Nucl Med; 1987 Nov; 28(11):1667-70. PubMed ID: 3499490
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 7. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB.
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [Abstract] [Full Text] [Related]

  • 8. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL, Kamo H, Harrop R, Li DK, Tuokko H, McGeer EG, Adam MJ, Ammann W, Beattie BL, Calne DB.
    CMAJ; 1986 Mar 15; 134(6):597-607. PubMed ID: 3512063
    [Abstract] [Full Text] [Related]

  • 9. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A, Newberg AB, Souder E, Berlin JA.
    J Nucl Med; 1993 Oct 15; 34(10):1681-7. PubMed ID: 8410281
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
    Dukart J, Mueller K, Horstmann A, Vogt B, Frisch S, Barthel H, Becker G, Möller HE, Villringer A, Sabri O, Schroeter ML.
    Neuroimage; 2010 Jan 15; 49(2):1490-5. PubMed ID: 19770055
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
    Fukuyama H, Ogawa M, Yamauchi H, Yamaguchi S, Kimura J, Yonekura Y, Konishi J.
    J Nucl Med; 1994 Jan 15; 35(1):1-6. PubMed ID: 8271029
    [Abstract] [Full Text] [Related]

  • 15. Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
    Jagust WJ, Seab JP, Huesman RH, Valk PE, Mathis CA, Reed BR, Coxson PG, Budinger TF.
    J Cereb Blood Flow Metab; 1991 Mar 15; 11(2):323-30. PubMed ID: 1997504
    [Abstract] [Full Text] [Related]

  • 16. Relatively preserved hippocampal glucose metabolism in mild Alzheimer's disease.
    Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E.
    Dement Geriatr Cogn Disord; 1998 Mar 15; 9(6):317-22. PubMed ID: 9769444
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C, Chiaravalloti A, Sancesario G, Stefani A, Sancesario GM, Mercuri NB, Schillaci O, Pierantozzi M.
    Eur J Nucl Med Mol Imaging; 2016 Oct 15; 43(11):2040-9. PubMed ID: 27221635
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
    Xiao SF, Cao QY, Xue HB, Liu YC, Zuo CT, Jiang KD, Zhang MY.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 09; 85(42):2975-9. PubMed ID: 16324383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.